Abstract:Aim: To study the effect of etoposide (VP16) on the death and apoptosis of SHG-44 glioma cell which expresses beta-1, 4-galactosyltransferase Vβ-1, 4-GalT V), so as to establish basis for further exploration of the relationship between β-1, 4-GalT V and sensitivity of anti-tumor drugs. Methods: The effects of VP16 of different concentrations on the apoptosis and death of SHG-44 cells transfected with senseβ-1, 4-GalT V (GalTV-HA/SHG-44), antisense β-1, 4-GalT V (GalTV-AS/SHG-44) and empty vector (Mock) were detected by flow cytometry (FCM) and Hoechst 33258 staining. Results: 1 Twenty-four hours after dealing with VP16 of low concentration (20 μmol/L), the ratio of dead cells and apoptosis cells in the GalTV-HA/SHG-44 group was obviously higher than those in the Mock group (t=4.550 6, P < 0.01) and GalTV-AS/SHG-44 group (t = 5.086 5, P < 0.001), and that in the GalTV-AS/SHG-44 group was obviously higher than that in the Mock group (t = 3.2873, P > 0.01). After dealing with VP16 of high concentration (120 μmoL/L) for 48 and 72 hours, the proportion of death cells in the GalTV-HA/SHG-44 group was obviously lower than that in the Mock group (t = 3.366 4, P < 0.05; t = 5.495 3, P < 0.01) and the GalTV-AS/SHG-44 group (t = 3.173 2, P < 0.01; t = 4.603 5, P < 0.001). 2 MIT analysis showed that after dealing with VP16 for 48 and 72 hours, the number of live cells in the GalTV-HA/SHG-44 group was obviously high than that in the Mock group (t = 5.078 3, P < 0.05; t = 3.892 3, P < 0.01) and GalTV-AS /SHG-44 group (t = 4.566 7, P < 0.01; t = 4.784 9, P < 0.001). 3 After dealing with VP16 for 24 hours, Hoechst 33258 staining was performed. Observation under fluorescence microscope showed that the cell nucleolus and disrupted segment of nucleus were showed crescent shape, or karyopyknosis and deeply dyed. The mean positive rate of death and apoptosis in the GalTV-AS/SHG-44 group was 41% , significantly higher than Mock and GalTV-HA/SHG-44 dealt with the same method. Conclusion: β-1, 4-GalT V can influence the killing and injuring effect of VP16 on SHG-44 cells, and overexpression of β-1, 4-GalT V can antagonize the effect of VP16, which provides new evidence for the explanation of the anti-tumor tolerance of glioma.

Studied on the Expression of Β-1,4-galactosyltransferase Ⅰ、Ⅱ and Ⅴ in Astrocytoma SHG-44 Treated by Etoposide

Effect of SHG-44 cells expressed beta-1,4-galactosyltransferase V on the sensitivity of etoposide

Expression of Β 1,4-Galactosyltransferase Mrna in Human Astrocytomas

Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells

Over-expression of Β-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Over-expression of ?-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Expression of Enos and VEGF in Association with Angiogenesis of Human Astrocytoma

Study of Effects of Β-1,4-galactosyltransferase V on Cellular Adhesion Ability of Human Astrocytoma SHG-44 Cells

Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line.

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Expression of cyclooxygenase-2 and VEGF in human glioma and its role

Expression and significance of vascuIar endothelial growth factor and VIII-R Ag in human brain glioma

Expression and significance of vascuIar endothelial growth factor and Ⅷ-R Ag in human brain glioma

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

The Specific Expression of ETV1 in Gastrointestinal Stromal Tumors

EXPRESSION OF GALβ-1,4-GIcNAc GROUP IN ASTROCYTOMA

β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma

Beta1,4-galactosyltransferase V A growth regulator in glioma.

Expressions of vascular endothelial growth factor gene protein in astrocytoma and its clinical significance

Regulation of the Beta 1,4-Galactosyltransferase I Promoter by E2f1

Evaluation of ST6Gal1 expression and clinicopathological significance in human glioma